✦ LIBER ✦

Sildenafil and phosphodiesterase-5 inhibitors for heart failure

✍ Scribed by Marco Guazzi

Book ID: 107539987
Publisher: Current Science Inc.
Year: 2008
Tongue: English
Weight: 305 KB
Volume: 5
Category: Article
ISSN: 1546-9530
DOI: 10.1007/s11897-008-0018-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sildenafil citrate, a selective phosphod

Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications

✍ A. Nehra; F. Colreavy; B. K. Khandheria; K. Chandrasekaran 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 73 KB

Phosphodiesterase-5 Inhibitors and Migra

Phosphodiesterase-5 Inhibitors and Migraine

✍ Randolph W. Evans; C. Kruuse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

ADMET considerations for phosphodiestera

ADMET considerations for phosphodiesterase-5 inhibitors

✍ Rezvanfar, Mohammad Amin; Rahimi, Hamid Reza; Abdollahi, Mohammad 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 390 KB

Type 5 phosphodiesterase inhibition in h

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension

✍ Gregory D. Lewis; Marc J. Semigran 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 332 KB

The emerging role for type 5 phosphodies

The emerging role for type 5 phosphodiesterase inhibition in heart failure

✍ Gregory D. Lewis; Marc J. Semigran 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 498 KB

The phosphodiesterase 5 inhibitor silden

The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway

✍ Anastasia Pyriochou; Zongmin Zhou; Vasiliki Koika; Christos Petrou; Paul Cordopa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

## Abstract cGMP‐degrading pathways have received little attention in the context of angiogenesis. In the present study we set out to determine whether cGMP‐specific phosphodiesterase 5 (PDE5) inhibition affects new blood vessel growth. Incubation of chicken chorioallantoic membranes (CAMs) in vivo